JP4979199B2 - 細胞培養基材及び細胞培養方法 - Google Patents
細胞培養基材及び細胞培養方法 Download PDFInfo
- Publication number
- JP4979199B2 JP4979199B2 JP2005120886A JP2005120886A JP4979199B2 JP 4979199 B2 JP4979199 B2 JP 4979199B2 JP 2005120886 A JP2005120886 A JP 2005120886A JP 2005120886 A JP2005120886 A JP 2005120886A JP 4979199 B2 JP4979199 B2 JP 4979199B2
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- water
- culture substrate
- cells
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004113 cell culture Methods 0.000 title claims description 95
- 239000000758 substrate Substances 0.000 title claims description 80
- 229920000642 polymer Polymers 0.000 claims description 85
- 239000000017 hydrogel Substances 0.000 claims description 69
- 239000000178 monomer Substances 0.000 claims description 38
- 239000000499 gel Substances 0.000 claims description 21
- 210000004748 cultured cell Anatomy 0.000 claims description 18
- 229920006037 cross link polymer Polymers 0.000 claims description 15
- 230000005855 radiation Effects 0.000 claims description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 7
- 238000010894 electron beam technology Methods 0.000 claims description 6
- WLPAQAXAZQUXBG-UHFFFAOYSA-N 1-pyrrolidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCC1 WLPAQAXAZQUXBG-UHFFFAOYSA-N 0.000 claims description 3
- 239000011557 critical solution Substances 0.000 claims description 3
- 230000005251 gamma ray Effects 0.000 claims description 3
- RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 claims description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 claims description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 2
- 229910000271 hectorite Inorganic materials 0.000 claims description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 claims description 2
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 2
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 claims description 2
- 229910000275 saponite Inorganic materials 0.000 claims description 2
- KVGJZBHVAIDSMT-UHFFFAOYSA-N N-ethyl-N-methylprop-2-enamide N-ethylprop-2-enamide Chemical compound C(C=C)(=O)N(C)CC.C(C=C)(=O)NCC KVGJZBHVAIDSMT-UHFFFAOYSA-N 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 85
- 238000006116 polymerization reaction Methods 0.000 description 35
- 239000002734 clay mineral Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 230000002209 hydrophobic effect Effects 0.000 description 17
- 230000001678 irradiating effect Effects 0.000 description 13
- 239000002904 solvent Substances 0.000 description 10
- -1 acrylic compound Chemical class 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000003431 cross linking reagent Substances 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 6
- 239000012498 ultrapure water Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000007870 radical polymerization initiator Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CCPHAMSKHBDMDS-UHFFFAOYSA-N Chetoseminudin B Natural products C=1NC2=CC=CC=C2C=1CC1(SC)NC(=O)C(CO)(SC)N(C)C1=O CCPHAMSKHBDMDS-UHFFFAOYSA-N 0.000 description 2
- 241000233803 Nypa Species 0.000 description 2
- 235000005305 Nypa fruticans Nutrition 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 229940094522 laponite Drugs 0.000 description 2
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- KAKALCZDCFZYRN-UHFFFAOYSA-N n-(2-ethoxyethyl)-2-methylprop-2-enamide Chemical compound CCOCCNC(=O)C(C)=C KAKALCZDCFZYRN-UHFFFAOYSA-N 0.000 description 2
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 2
- KPEKHIHQXHOSRM-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound C=CC(=O)NCC1CCCO1 KPEKHIHQXHOSRM-UHFFFAOYSA-N 0.000 description 2
- FIBUWQFQYAAXHD-UHFFFAOYSA-N n-cyclopropyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1CC1 FIBUWQFQYAAXHD-UHFFFAOYSA-N 0.000 description 2
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 description 1
- XLPJNCYCZORXHG-UHFFFAOYSA-N 1-morpholin-4-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCOCC1 XLPJNCYCZORXHG-UHFFFAOYSA-N 0.000 description 1
- KGFNCEVZZDDBTR-UHFFFAOYSA-N 1-piperazin-1-ylbut-3-en-2-one Chemical compound C=CC(=O)CN1CCNCC1 KGFNCEVZZDDBTR-UHFFFAOYSA-N 0.000 description 1
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- JJOYJOCWEDSDOO-UHFFFAOYSA-N 2-methyl-n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound CC(=C)C(=O)NCC1CCCO1 JJOYJOCWEDSDOO-UHFFFAOYSA-N 0.000 description 1
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 1
- MTPJEFOSTIKRSS-UHFFFAOYSA-N 3-(dimethylamino)propanenitrile Chemical compound CN(C)CCC#N MTPJEFOSTIKRSS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000871495 Heeria argentea Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000003320 cell separation method Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- DFENKTCEEGOWLB-UHFFFAOYSA-N n,n-bis(methylamino)-2-methylidenepentanamide Chemical compound CCCC(=C)C(=O)N(NC)NC DFENKTCEEGOWLB-UHFFFAOYSA-N 0.000 description 1
- FOGSDLLFGSNQCW-UHFFFAOYSA-N n-[(prop-2-enoylamino)methoxymethyl]prop-2-enamide Chemical compound C=CC(=O)NCOCNC(=O)C=C FOGSDLLFGSNQCW-UHFFFAOYSA-N 0.000 description 1
- UBTYFVJZTZYJHZ-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)propyl]prop-2-enamide Chemical compound C=CC(=O)NC(C)CNC(=O)C=C UBTYFVJZTZYJHZ-UHFFFAOYSA-N 0.000 description 1
- DJVKJGIZQFBFGS-UHFFFAOYSA-N n-[2-[2-(prop-2-enoylamino)ethyldisulfanyl]ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCSSCCNC(=O)C=C DJVKJGIZQFBFGS-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- ZOTWHNWBICCBPC-UHFFFAOYSA-N n-ethyl-n-methylprop-2-enamide Chemical compound CCN(C)C(=O)C=C ZOTWHNWBICCBPC-UHFFFAOYSA-N 0.000 description 1
- RGNKVBUBMHKKJP-UHFFFAOYSA-N n-methyl-n-propylprop-2-enamide Chemical compound CCCN(C)C(=O)C=C RGNKVBUBMHKKJP-UHFFFAOYSA-N 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920001078 poly (N-Isopropyl methacrylamide) Polymers 0.000 description 1
- 229920001977 poly(N,N-diethylacrylamides) Polymers 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920000208 temperature-responsive polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical group C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明の二重架橋型高分子ゲルを得る際に、高分子ヒドロゲルに照射する放射線としては、電子線、ガンマ線、X線、紫外線、可視光などを用いることができるが、有機モノマーの重合体の架橋反応を起こすこと、及び高分子ヒドロゲルの滅菌を十分に行うことが可能である、電子線、またはガンマ線を用いることが好ましい。放射線の線量は、有機モノマーの重合体の必要とする二重架橋の程度により任意に調節可能であるが、好ましくは1kGy〜50kGyの範囲であり、より好ましくは5kGy〜20kGyの範囲である。1kGy以上の線量で照射することにより、高分子ヒドロゲルの内部まで架橋反応が起こるようになり、また50kGy以下の線量であれば、高分子ヒドロゲルの放射線照射による劣化を抑制することが可能となる。
粘土鉱物には、[Mg5.34Li0.66Si8O20(OH)4]Na+ 0.66の組成を有する水膨潤性合成ヘクトライト(Rockwood Ltd.製「ラポナイトXLG」)を真空乾燥して用いた。有機モノマーは、N−イソプロピルアクリルアミド(興人株式会社製:以下、NIPAと略記。)を既知の方法により精製して、重合禁止剤を取り除いてから使用した。重合開始剤は、ペルオキソ二硫酸カリウム(関東化学株式会社製:以下、KPSと略記。)をKPS/水=0.40/20(g/g)の割合で脱酸素した超純水中に溶解し、水溶液にして使用した。重合促進剤は、N,N,N’,N’−テトラメチルエチレンジアミン(和光純薬工業株式会社製:以下、TEMEDと略記。)を使用した。超純水は、全て微粒子除去用フィルターを通した高純度窒素をあらかじめ充分にバブリングさせ、含有酸素を除去してから使用した。
上記実施例1で得られた細胞培養基材(A)を載せた細胞培養ディッシュを用いて、細胞の培養を行った。培養する細胞は、正常ヒト皮膚繊維芽細胞(大日本製薬株式会社製)を使用した。培養は、CS−C培地(大日本製薬株式会社製)を使用して、5%二酸化炭素含有37℃恒温器内で行った。播種してから1週間後、このディッシュ内の細胞培養基材(A)の端を一部切り取り、20℃恒温槽内に5分間静置してから、表面を光学顕微鏡にて観察したところ、細胞が細胞培養基材(A)上に接着して、また十分に増殖していたことが確認された。この培養を行った細胞培養基材(A)含有ディッシュから細胞培養基材(A)を培養した細胞ごと取り出して、あらかじめ20℃に保持しておいたCS−C培地を含む組織培養ディッシュに移し替えた。蓋をしてから20℃で10分間静置後、細胞培養基材(A)上に増殖した細胞をピンセットで摘むことにより、細胞をシート状に細胞培養基材(A)から分離できた。この時、細胞培養基材(A)に何ら損傷はなく、またシート状の細胞にも何ら付着物は見られなかった。この取り出したシート状細胞についてトリプシン−EDTA処理を行うことにより、各細胞を個々の状態に分離した後、トリパンブルー染色を行うことによって、生細胞数を計測したところ、培養開始時には2.5×106個であった細胞数が、培養後は5.8×107個に増加したことが確認された。
XLGを2.4g加えること、及び得られたヒドロゲルに照射する電子線の線量を10kVとすること以外は実施例1と同様にして、無色透明で均一なシート状のヒドロゲル(B)を得た。シート状のヒドロゲル(B)の引っ張り試験を実施例1と同様の方法で行ったところ、引っ張り破断強度が190kPa、破断伸びが120%、弾性率が41.7kPaであった。このシート状のヒドロゲル(B)を、作製例1と同様にして、精製を行った後、直径8cmの大きさに切断して細胞培養基材(B)とした。得られた細胞培養基材(B)の表面に置ける接触角は、50℃保持状態で61°であった。
細胞培養用ディッシュ「ファルコン3003」を何も表面処理を行わずに使用して、細胞培養を行った。細胞及び培地、培養条件は実施例2と同様にして行った。培養開始から1週間後にディッシュ表面を光学顕微鏡にて観察したところ、細胞が接着して増殖していることが確認された。この培養を行ったディッシュを20℃の恒温槽に入れて,10分間静置後、ディッシュ上の細胞を取り出そうとしたが、全く剥離しなかった。また、公知の方法により、トリプシンを用いて培養細胞の分離を行ったところ、細胞が個々の細胞に分かれてしまい、細胞をシート状に取り出すことは不可能であった。
粘土鉱物を用いないこと以外は作製例1と同様にして、有機架橋ヒドロゲルを重合した。有機架橋剤としては、N,N’−メチレンビスアクリルアミド(和光純薬工業株式会社製)をそのまま使用した。その結果、20℃において白色化したシート状のヒドロゲル(D)が得られた。この得られたシート状のヒドロゲル(D)を作製例1と同様にして、精製を行ってから、細胞培養用ディッシュに移し替えたが、ヒドロゲルシート(D)は非常に脆く、精製及び移し替えは困難であった。またこのヒドロゲルシート(D)の接触角は、50℃保持状態で49°であった。
Claims (4)
- N−イソプロピル(メタ)アクリルアミド、N−n−プロピル(メタ)アクリルアミド、N−シクロプロピル(メタ)アクリルアミド、N−エトキシエチル(メタ)アクリルアミド、N−テトラヒドロフルフリル(メタ)アクリルアミド、N−エチルアクリルアミド、N−エチル−N−メチルアクリルアミド、N,N−ジエチルアクリルアミド、N−メチル−N−n−プロピルアクリルアミド、N−メチル−N−イソプロピルアクリルアミド、N−アクリロイルピペリディン及びN−アクリロイルピロリディンからなる群から選ばれる少なくとも一種の水溶性有機モノマーの重合体と、水膨潤性のヘクトライト、水膨潤性のモンモリロナイト、水膨潤性のサポナイト、水膨潤性の合成雲母からなる群から選ばれる少なくとも一種の水膨潤性粘土鉱物とから構成される三次元網目構造を有する高分子ヒドロゲルにガンマ線、及び電子線から選ばれる少なくとも一種の放射線を照射線量が1kGy〜50kGyの範囲となるように照射してなる二重架橋型高分子ゲルからなり、かつ、外部環境変化にともない親水性と疎水性とが可逆的に変化することを特徴とする細胞培養基材。
- 前記二重架橋型高分子ゲルが、一定の温度を境界にして親水性と疎水性とが可逆的に変化する二重架橋型高分子ゲルである請求項1に記載の細胞培養基材。
- 前記水溶性有機モノマーの重合体が、下限臨界共溶温度を有する請求項1又は2に記載の細胞培養基材。
- 請求項1〜3のいずれかに記載の細胞培養基材を使用して、該細胞培養基材が疎水性を示す温度で細胞を培養した後、該細胞培養基材の温度を下げ、該細胞培養基材が親水性を示す温度とすることにより培養した細胞を該細胞培養基材から分離する細胞培養方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005120886A JP4979199B2 (ja) | 2005-04-19 | 2005-04-19 | 細胞培養基材及び細胞培養方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005120886A JP4979199B2 (ja) | 2005-04-19 | 2005-04-19 | 細胞培養基材及び細胞培養方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006296257A JP2006296257A (ja) | 2006-11-02 |
JP4979199B2 true JP4979199B2 (ja) | 2012-07-18 |
Family
ID=37465126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005120886A Expired - Fee Related JP4979199B2 (ja) | 2005-04-19 | 2005-04-19 | 細胞培養基材及び細胞培養方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4979199B2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5028082B2 (ja) * | 2006-12-21 | 2012-09-19 | 一般財団法人川村理化学研究所 | 局所膨潤高分子ゲル |
EP2112196A1 (en) * | 2008-04-25 | 2009-10-28 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | A liquid composition comprising polymer chains and particles of an inorganic material in a liquid |
KR101877892B1 (ko) * | 2016-07-25 | 2018-07-12 | 주식회사 메디팹 | 이중가교를 갖는 3차원 세포배양 지지체 제조방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4792624B2 (ja) * | 2000-08-07 | 2011-10-12 | Dic株式会社 | 液晶組成物 |
-
2005
- 2005-04-19 JP JP2005120886A patent/JP4979199B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2006296257A (ja) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2292691B1 (en) | Organic-inorganic complex dispersion, cell culture substratum manufactured by using the dispersion, and manufacturing methods for same | |
US7993892B2 (en) | Production of organic/inorganic composite hydrogel | |
JP5880181B2 (ja) | 有機無機複合ヒドロゲル | |
JP5349728B2 (ja) | 細胞培養基材及び細胞培養方法 | |
JP6493629B2 (ja) | 細胞培養基材 | |
JP2008237088A (ja) | 細胞培養基材及び細胞培養方法 | |
WO2019035436A1 (ja) | 多能性幹細胞の培養基材及び多能性幹細胞の製造方法 | |
JP2020062009A (ja) | 細胞培養基材、細胞培養基材の製造方法、及びスフェロイドの製造方法 | |
JP5460302B2 (ja) | 有機無機複合体分散液の製造方法 | |
JP4979199B2 (ja) | 細胞培養基材及び細胞培養方法 | |
JP2006271252A (ja) | 細胞培養基材及び細胞培養方法 | |
JP7271870B2 (ja) | 多能性幹細胞の培養基材及び多能性幹細胞の製造方法 | |
JP2010193743A (ja) | 細胞培養基材及びその製造方法 | |
JP2006288251A (ja) | 細胞培養基材及び細胞培養方法 | |
JP2006288217A (ja) | 細胞培養基材及び細胞培養方法 | |
JP5935477B2 (ja) | 骨髄由来細胞の培養方法 | |
JP2006280206A (ja) | 細胞培養基材及び細胞培養方法 | |
JP6024796B2 (ja) | 細胞培養基材及び細胞培養方法 | |
JPH04126071A (ja) | 細胞培養用支持体 | |
JPH0538278A (ja) | 細胞培養支持体材料 | |
JPH0494679A (ja) | 細胞培養支持体材料 | |
JP7183612B2 (ja) | 多能性幹細胞の培養基材及び多能性幹細胞の製造方法 | |
JP2013176402A (ja) | 細胞培養基材及び細胞培養方法 | |
JP2012050394A (ja) | 角膜細胞の培養方法及び培養角膜細胞 | |
JP2012050395A (ja) | 網膜色素細胞の培養方法及び培養網膜色素細胞 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20071220 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080307 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100930 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101112 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111027 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120417 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120417 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150427 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4979199 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313114 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |